Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipose Tissue, White | 4 | 2024 | 362 | 1.260 |
Why?
|
Physical Conditioning, Animal | 3 | 2024 | 366 | 1.030 |
Why?
|
Follistatin | 3 | 2013 | 137 | 0.860 |
Why?
|
Myostatin | 3 | 2013 | 129 | 0.840 |
Why?
|
Activins | 3 | 2013 | 210 | 0.820 |
Why?
|
Adaptation, Physiological | 3 | 2024 | 1301 | 0.720 |
Why?
|
Cold Temperature | 1 | 2024 | 783 | 0.710 |
Why?
|
Fibronectins | 3 | 2016 | 724 | 0.520 |
Why?
|
Food Deprivation | 1 | 2011 | 114 | 0.380 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22128 | 0.300 |
Why?
|
Leptin | 2 | 2011 | 1595 | 0.270 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2020 | 3417 | 0.250 |
Why?
|
Obesity, Morbid | 2 | 2013 | 1278 | 0.250 |
Why?
|
Energy Metabolism | 1 | 2016 | 2877 | 0.240 |
Why?
|
Lipids | 1 | 2016 | 3331 | 0.240 |
Why?
|
Homeostasis | 1 | 2016 | 3322 | 0.240 |
Why?
|
Insulin Antagonists | 1 | 2023 | 17 | 0.220 |
Why?
|
Hydrocortisone | 1 | 2011 | 1818 | 0.220 |
Why?
|
Insulinoma | 1 | 2023 | 121 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.200 |
Why?
|
Subcutaneous Fat | 1 | 2024 | 393 | 0.180 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.170 |
Why?
|
Muscle, Skeletal | 2 | 2022 | 4947 | 0.170 |
Why?
|
Thermogenesis | 1 | 2024 | 477 | 0.170 |
Why?
|
Adipose Tissue | 3 | 2023 | 3313 | 0.150 |
Why?
|
Adiponectin | 2 | 2016 | 1107 | 0.150 |
Why?
|
Sex Characteristics | 2 | 2024 | 2640 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2023 | 883 | 0.130 |
Why?
|
Insulin | 2 | 2023 | 6588 | 0.130 |
Why?
|
Peptide YY | 1 | 2016 | 135 | 0.120 |
Why?
|
Incretins | 1 | 2016 | 99 | 0.120 |
Why?
|
GPI-Linked Proteins | 1 | 2016 | 470 | 0.120 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2016 | 392 | 0.120 |
Why?
|
Proteome | 1 | 2024 | 1856 | 0.120 |
Why?
|
Benzazepines | 1 | 2016 | 310 | 0.110 |
Why?
|
Ghrelin | 1 | 2016 | 251 | 0.110 |
Why?
|
C-Peptide | 1 | 2016 | 442 | 0.110 |
Why?
|
Lectins | 1 | 2016 | 489 | 0.110 |
Why?
|
Glucagon | 1 | 2016 | 531 | 0.110 |
Why?
|
Cyprus | 1 | 2013 | 96 | 0.110 |
Why?
|
Motor Activity | 1 | 2023 | 2712 | 0.100 |
Why?
|
Anti-Obesity Agents | 1 | 2016 | 227 | 0.100 |
Why?
|
Glucose | 1 | 2024 | 4342 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1645 | 0.100 |
Why?
|
Juglans | 1 | 2011 | 45 | 0.090 |
Why?
|
Clusterin | 1 | 2011 | 71 | 0.090 |
Why?
|
Sulfonylurea Compounds | 1 | 2013 | 219 | 0.090 |
Why?
|
Anticarcinogenic Agents | 1 | 2013 | 249 | 0.090 |
Why?
|
Infusions, Intravenous | 1 | 2016 | 2217 | 0.090 |
Why?
|
PPAR gamma | 1 | 2013 | 483 | 0.090 |
Why?
|
Apolipoprotein A-I | 1 | 2011 | 299 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2016 | 863 | 0.090 |
Why?
|
Administration, Oral | 1 | 2016 | 4015 | 0.070 |
Why?
|
Body Mass Index | 3 | 2013 | 12952 | 0.070 |
Why?
|
Double-Blind Method | 4 | 2016 | 12341 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5366 | 0.060 |
Why?
|
Metformin | 1 | 2013 | 910 | 0.060 |
Why?
|
Weight Loss | 2 | 2016 | 2680 | 0.060 |
Why?
|
Body Weight | 2 | 2016 | 4618 | 0.060 |
Why?
|
Male | 11 | 2024 | 360703 | 0.060 |
Why?
|
Metabolic Diseases | 1 | 2011 | 680 | 0.060 |
Why?
|
Mice | 4 | 2024 | 81330 | 0.060 |
Why?
|
Adult | 7 | 2020 | 221120 | 0.050 |
Why?
|
Acclimatization | 1 | 2023 | 113 | 0.050 |
Why?
|
Bariatric Surgery | 1 | 2012 | 991 | 0.050 |
Why?
|
Cholesterol | 1 | 2011 | 2902 | 0.050 |
Why?
|
Animals | 6 | 2024 | 168089 | 0.050 |
Why?
|
RNA, Messenger | 2 | 2013 | 12747 | 0.050 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2023 | 263 | 0.050 |
Why?
|
Adipogenesis | 1 | 2024 | 368 | 0.050 |
Why?
|
Blood Glucose | 1 | 2016 | 6392 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2021 | 71 | 0.050 |
Why?
|
Cytokines | 1 | 2016 | 7386 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3691 | 0.050 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2021 | 91 | 0.040 |
Why?
|
Hypoglycemic Agents | 1 | 2013 | 3089 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 186 | 0.040 |
Why?
|
Transcription Factors | 2 | 2023 | 12101 | 0.040 |
Why?
|
Adipose Tissue, Brown | 1 | 2023 | 766 | 0.040 |
Why?
|
Humans | 11 | 2023 | 761222 | 0.030 |
Why?
|
Exercise | 1 | 2012 | 5874 | 0.030 |
Why?
|
Female | 9 | 2024 | 392552 | 0.030 |
Why?
|
Cross-Sectional Studies | 2 | 2013 | 26072 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2415 | 0.030 |
Why?
|
Middle Aged | 5 | 2016 | 220858 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 1 | 2024 | 8164 | 0.030 |
Why?
|
Selectins | 1 | 2011 | 101 | 0.020 |
Why?
|
Young Adult | 2 | 2016 | 59222 | 0.020 |
Why?
|
Serum Amyloid A Protein | 1 | 2011 | 126 | 0.020 |
Why?
|
Lipolysis | 1 | 2012 | 210 | 0.020 |
Why?
|
Thrombomodulin | 1 | 2011 | 105 | 0.020 |
Why?
|
Cues | 1 | 2016 | 875 | 0.020 |
Why?
|
Obesity | 3 | 2022 | 12940 | 0.020 |
Why?
|
Resistin | 1 | 2011 | 172 | 0.020 |
Why?
|
Carcinogens | 1 | 2013 | 452 | 0.020 |
Why?
|
Periodicity | 1 | 2011 | 347 | 0.020 |
Why?
|
Brain | 1 | 2016 | 27094 | 0.020 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2011 | 691 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 12159 | 0.020 |
Why?
|
Hormones | 1 | 2012 | 868 | 0.020 |
Why?
|
Energy Intake | 1 | 2016 | 2133 | 0.020 |
Why?
|
Glycolysis | 1 | 2012 | 836 | 0.020 |
Why?
|
Rats | 1 | 2024 | 23705 | 0.020 |
Why?
|
Thinness | 1 | 2011 | 481 | 0.020 |
Why?
|
Interleukins | 1 | 2011 | 782 | 0.020 |
Why?
|
Placebos | 1 | 2011 | 1666 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2012 | 1988 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2011 | 2854 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1603 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2011 | 2082 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2021 | 18927 | 0.020 |
Why?
|
Athletes | 1 | 2012 | 1138 | 0.010 |
Why?
|
Emotions | 1 | 2016 | 2742 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 22142 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2916 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6304 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2380 | 0.010 |
Why?
|
Body Composition | 1 | 2011 | 2427 | 0.010 |
Why?
|
Aged | 1 | 2013 | 169292 | 0.010 |
Why?
|
Risk | 1 | 2013 | 9616 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2011 | 4340 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3821 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11855 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36415 | 0.000 |
Why?
|
Signal Transduction | 1 | 2011 | 23419 | 0.000 |
Why?
|
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_